期刊文献+

用于抑制肿瘤细胞生长的叶酸修饰聚多巴胺涂层的氧化铜纳米颗粒

Folic acid modified copper oxide nanoparticles coated with polydopamine for inhibition of tumor cell growth
下载PDF
导出
摘要 采用沉淀转化法制备出粒径约为10 nm的氧化铜纳米颗粒(CuO NPs),通过盐酸多巴胺(DA HCl)在其表面进行聚合,并通过叶酸(FA)修饰形成CuO@PDA-FA NPs。采用透射电子显微镜、红外光谱仪、纳米粒径电势分析仪、X射线光电子能谱对纳米颗粒的形貌和性质进行表征。结果表明,制备的CuO@PDA-FA NPs粒径约为190 nm。材料降解亚甲基蓝试验和氧化葡萄糖试验证实CuO@PDA-FA NPs具备类过氧化物酶(POD)活性和类葡萄糖氧化酶(GOD)活性。近红外光热转换试验证实CuO@PDA-FA NPs具有良好的光热效应和光热稳定性。体外细胞毒性试验、细胞摄取试验和活性氧生成试验结果表明,CuO@PDA-FA NPs能主动靶向肿瘤细胞,并通过光热治疗(PTT)/化学动力学治疗(CDT)/饥饿治疗(ST)协同效果杀伤肿瘤细胞。 Copper oxide nanoparticles(CuO NPs)with the size of about 10 nm were prepared by precipitation transformation method,and CuO@PDA-FA NPs were synthesized by polymerization of dopamine hydrochloride(DA HCl)and modification of folic acid(FA)on its surface.The morphology and properties of the nanoparticles were characterized by transmission electron microscope,infrared spectrometer,nano-particle size potential analyzer and X-ray photoelectron spectroscopy.The results show that CuO@PDA-FA NPs with a particle size of about 190 nm are prepared.The degradation of methylene blue and glucose oxide confirmed that the material has peroxidase(POD)activity and glucose oxidase(GOD)activity.Near-infrared photothermal conversion experiments show that it has good photothermal effect and photothermal stability.The results of in vitro cytotoxicity test,cell uptake test and reactive oxygen generation test show that CuO@PDA-FA NPs can actively target tumor cells and kill tumor cells through the synergistic effect of photothermal therapy(PTT),chemical dynamic therapy(CDT)and starvation therapy(ST).
作者 邓凯夫 郑轶璐 王通 郑之裕 修梦婷 任蓉 VAN CUONG Nguyen 朱利民 DENG Kaifu;ZHENG Yilu;WANG Tong;ZHENG Zhiyu;XIU Mengting;REN Rong;VAN CUONG Nguyen;ZHU Limin(College of Biological Science and Medical Engineering,Donghua University,Shanghai,China;Shanghai Engineering Research Center of Nano-Biomaterials and Regenerative Medicine,Donghua University,Shanghai,China;Faculty of Chemical Engineering,Industrial University of Ho Chi Minh City,Ho Chi Minh,Vietnam)
出处 《东华大学学报(自然科学版)》 CAS 北大核心 2024年第2期59-69,共11页 Journal of Donghua University(Natural Science)
基金 上海市科学技术委员会资助项目(22520710400,21WZ2501300,20DZ2254900) 中国教育部生物医用纺织材料“111工程”(B07024)。
关键词 氧化铜 纳米颗粒 叶酸 聚多巴胺 化学动力学治疗 光热治疗 模拟酶 copper oxide nanoparticle folic acid polydopamine chemodynamic therapy photothermal therapy mimic enzyme
  • 相关文献

参考文献3

二级参考文献18

  • 1Ratnam M, Marquardt H, Duhring JL, et al. Homologous membrane folate binding proteins in human placenta: cloning and sequence of a cDNA [J]. Biochemistry, 1989, 28 (20): 8249-8254. 被引量:1
  • 2Lacey SW, Sanders JM, Rothberg KG, et al. Complementary DNA for the folate binding protein correctly predicts anchoring to the membrane by glycosyl-phosphatidylinositol [J]. J Clin Invest, 1989, 84(2): 715-720. 被引量:1
  • 3Coney LR, Tomassetti A, Carayannopoulos L, et al. Cloning of a tumor-associated antigen: MOv18 and MOv19 antibodies recognize a folate-binding protein[J]. Cancer Res, 1991, 51(22): 6125-6132. 被引量:1
  • 4Antony AC. The biological chemistry of folate receptors [J]. Blood, 1992, 79(11): 2807-2820. 被引量:1
  • 5Weitman SD, Weinberg AG, Coney LR, et al. Cellular localization of the folate receptor: potential role in drug toxicity and folate homeostasis[J]. Cancer Res, 1992, 52(23): 6708-6711. 被引量:1
  • 6Ross JF, Chaudhuri PK, Ratnam M. Diffierential regulation of folate receptor isoforms in normal malignant tissues in vivo and in established cell lines [J]. Cancer, 1994, 73: 2432-2443. 被引量:1
  • 7Wang X, Shen F, Freisheim JH, et al. Differential stereospicifities and affinity of folate receptor isoforms for folate compounds and antifolates [J]. Biochem Pharmacol, 1992, 44: 1898-1901. 被引量:1
  • 8Visser GW, Klok RP, Gebbinck JW, et al. Optimal quality (131)I-monoclonal antibodies on high-dose labeling in a large reaction volume and temporarily coating the antibody with IODO-GEN[J]. J Nucl Med, 2001, 42(3): 509-519. 被引量:1
  • 9Casalini P, Luison E, Menard S, et al. Tumor pretargeting: role of avidin/streptavidin on monoclonal antibody internalization[J]. J Nucl Med, 1997, 38(9): 1378-1381. 被引量:1
  • 10Crippa F, Bolis G, Seregni E, et al. Single-dose intraperitoneal radioimmunotherapy with the murine monoclonal antibody I-131 MOv18: clinical results in patients with minimal residual disease of ovarian cancer [J]. Eur J Cancer, 1995, 31A(5): 686-690. 被引量:1

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部